View drug registration information details.
Items | Registration information |
ID | 170 |
No | 170 |
Brand Name | LANZAAR 50 |
Ingredients | LOSARTAN POTASSIUM 50 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | ALU-PVDC BLISTERPACK |
Storage | STORE BELOW 30'C, |
Shelf Life | 2 YEARS AFTER MANUFACTURE |
Pack Size | 3 X 10'S /BOX |
Dispensing Category | Prescription only |
ATC Classification | C09CA01 |
Pharmaceutical Class | HYPERTENSION |
Indications | TREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION. STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY |
Contraindications | - HYPERSENSITIVITY TO OTHER ANGIOTENSIN II RECEPTOR ANTAGONISTS
- BILATERAL RENAL ARTERY STENOSIS - PREGNANCY ( 2 ND AND 3RD TRIMESTERS) |
Side Effects | > 10% : CHEST PAIN, FATIGUE, HYPOGLYCEMIA, DIARRHEA, URINARY TRACT INFECTION, ANEMIA, WEAKNESS, BACK PAIN, COUGH 1% TO 10% |
Unit Price | - |
EDL |
No |
Description | WHITE OVAL BICONVEX FILM COATED TABLETS WITH ''BERLIN'' ON ONE SIDE AND SCORED BETWEEN "L" AND "50" ON THE OTHER SIDE |
Note | |
License Owner | BERLIN PHARMA LAO CO.,LTD |
Manufacturer | BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
Country | THAILAND |
Import Registration No | 1A 20/53 ( NG) |
Import Registration Date | 2010-07-23 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2022-07-08 |
FDD Registration No | 03 I 3710/12 |
FDD Registration Date | 2022-09-14 |
Expiry Date | 2025-09-13 |
Back to drug list
|